Antec Medical, Chengyi Bio, and Skynor Medical Founder Zhao Zhenxin Honored as '2024 Zhangjiang Emerging Stars in Life Health Industry'

Nov 19, 2024 10:21 CST Updated 10:21

Artechmed

Medical Device and Equipment Developer

Eccogene

Small Molecule Drug Developer

Skynor Medical

Vascular Minimally Invasive Intervention Product Developer

To implement the strategic deployments of the CPC Central Committee and the State Council, comprehensively promote the key tasks of building a Healthy China, and accelerate the new industrialization process of China's pharmaceutical industry, the 2024 China Pharmaceutical Industry Development Conference and Shanghai International Biomedical Industry Week opened at the Zhangjiang Science Hall on November 16.

This forum, themed "Crossing Mountains and Seas, Moving Towards the New," features "Shared Openness: Global Innovation Release" and "Innovation Origins: Zhangjiang Global Dialogue." It focuses on industrial ecosystems, new quality productivity, and global strategies to introduce innovative releases. Gathering cutting-edge technologies and emerging fields such as brain-computer interfaces, nuclear medicine, AI-driven drug discovery, and specialized large models, it unites experts and innovation resources from home and abroad. The event promotes in-depth integration and cooperation among large, medium, and small enterprises, builds a seamless bridge between innovation and industry, fosters a global scientific and technological innovation ecosystem for life sciences, and advances the development of new quality productivity in life sciences.

On the afternoon of November 17, the "Zhangjiang Life Health Industry Annual Rising Star Figures/Companies • 2024" list was grandly announced at the Zhangjiang Synergistic New Quality Development Forum. 10 rising star companies and 8 rising star figures received this honor.

Among them, Zhangke Herun's portfolio companiesArtechmed, Eccogene Inc. Honored as "2024 Zhangjiang Life Science and Health Industry Annual Rising Star Enterprises"; Zhangjiang Kaitou's portfolio companyZhao Zhenxin, Founder of Skynor Medical (Shanghai) Co., Ltd., Awarded "2024 Zhangjiang Life Science and Health Industry Annual Rising Star"。

Artechmed was founded in 2017, with its headquarters located in the International Medical Park of Zhangjiang Science City, Shanghai, focusing on innovative solutions for cardiac electrophysiology diagnosis and treatment. The company has dual product technology platforms in cryoballoon ablation (CBA) and pulsed field ablation (PFA), along with dozens of core independent intellectual property rights. The key team members all have extensive work experience in well-known medical device companies and possess rich expertise in the research and development, production, clinical development, commercialization, and company operations of products in the fields of electrophysiological diagnosis and treatment, cardiovascular and cerebrovascular interventions, cryoablation, and active medical devices.

Eccogene is aA clinical-stage biopharmaceutical company dedicated to providing innovative therapeutic solutions to address unmet global clinical needs. The company focuses on the discovery and development of translational medicine for metabolic and immune-related diseases.。

Skynor Medical, founded in 2014 and located in the Shanghai International Medical Park, focuses on the research, development, and production of high-end minimally invasive vascular interventional products. With two main product lines—neurointerventional and peripheral interventional—it positions itself as a platform company specializing in these fields, providing comprehensive treatment solutions for patients with stroke and peripheral arterial/venous vascular diseases.